24/7 Patient Assistance: 760-405-8205

Daniel Sterman, MD


Write a review
Doctor's profile photo

Request a call back

Conditions Treated Asbestosis Lung Cancer Pleural Effusions

specialties & services

  • Bio & Insurance Information

    As the clinical director of the Thoracic Oncology Gene Therapy Program, Dr. Daniel Sterman specializes in thoracic oncology, with an emphasis on malignant mesothelioma. Dr. Sterman graduated from Cornell University Medical College in 1989 and completed his residency at the University of Pennsylvania. He was a fellow at the same university. Dr. Sterman’s specialty is thoracic oncology, but his main area of focus has been mesothelioma and more effective treatments methods for quite a while. He has published several works, most relating to mesothelioma and the way it could be treated using human gene therapy. Dr. Daniel Sterman’s clinical trials have helped advance cancer treatments in the last few years.

  • Education & Training


    Brown University - 1985



    Cornell University Medical College - 1989

    Medical School


    University of Pennsylvania



    Hospital of the University of Pennsylvania


  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Critical Care Medicine

    American Board of Internal Medicine - Pulmonary Disease

  • Hospital & Practice

    Abramson Cancer Center Hospital University of Pennsylvania (HUP)

    Languages: English/Spanish

    (800) 789-7366

    University of Pennsylvania, 3400 Civic Center Blvd

    Philadelphia, Pennsylvania 19104

    Read More

    Penn Presbyterian Medical Center

    Languages: English/Spanish

    (215) 662-8000

    51 N 39th St

    Philadelphia, Pennsylvania 19104

    Read More
  • Publications & Memberships

    Dr. Daniel Sterman has contributed to 4 publications.

    Clinical presentation, diagnosis, and staging of malignant pleural mesothelioma.

    Sterman DH, Kaiser LR, Litzky LA, Albelda SM

    See more >>

    Epidemiology of malignant mesothelioma.

    Sterman DH, Kaiser LR, Litzky LA, Albelda SM

    See more >>

    Pilot and feasibility trial of immuno-gene therapy of malignant mesothelioma using intrapleural delivery of adenovirus-interferon-alpha combined with chemotherapy

    Sterman DH1, Alley E2, Stevenson JP2, Friedberg J3, Metzger S1, Recio A1, Moon EK1, Haas AR1, Vachani A1, Katz SI4, Sun J1, Heitjan DF5, Hwang WT5, Litzky L6, Yearley JH7, Tan KS5, Papasavvas E8, Kennedy P1, Montaner LJ8, Cengel KA9, Simone CB 2nd9, Culligan M3, Langer CJ2, Albelda SM10.

    See more >>

    Immunotherapy for non-small cell lung cancer: current concepts and clinical trials.

    Mayor, M.,Yang, N.,Sterman, D.,Jones, D. R.,Adusumilli, P. S.; Eur J Cardiothorac Surg.

    See more >>